Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Uloric U-Turn: Gout Therapy Likely To Stay On Market Despite CV Safety Concern
Jan 18 2019
•
By
Michael McCaughan
More from Drug Safety
More from Pink Sheet